The effectiveness of the gonadotropin-releasing hormone analogues in the treatment of endometriosis-associated pain

Giovanni Buzzaccarini; Giovanni Campo; Tito Silvio Patrelli

doi:10.1016/b978-0-443-27757-3.00012-2

The effectiveness of the gonadotropin-releasing hormone analogues in the treatment of endometriosis-associated pain

Giovanni Buzzaccarini, Giovanni Campo, Tito Silvio Patrelli

In: The Hormonal Treatment of Endometriosis and Adenomyosis · 2026 · pp. 133–145 · doi:10.1016/b978-0-443-27757-3.00012-2 · W7223413439

OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex

⚙ AI-generated summary by qwen3.7-flash, 2026-10-25 ⓘ

The paper evaluates the effectiveness of gonadotropin-releasing hormone analogues in treating pain associated with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (38)

Source provenance

openalex: last seen: 2026-10-26T06:07:52.047309+00:00

License: CC0 · commercial use OK

[1] A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review via openalex

[2] An update on the pharmacological management of endometriosis via openalex

[3] Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial via openalex

[4] Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study via openalex

[5] Current and emerging treatment options for endometriosis via openalex

[6] Deep Dyspareunia in Endometriosis: Role of the Bladder and Pelvic Floor via openalex

[7] Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis via openalex

[8] Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex

[9] Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex

[10] Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial via openalex

[11] Effects of triptorelin versus placebo on the symptoms of endometriosis via openalex

[12] Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis via openalex

[13] Endometriosis: current therapies and new pharmacological developments via openalex

[14] Endometriosis: pathogenesis and treatment via openalex

[15] Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin via openalex

[16] Gonadotropin-releasing hormone and its analogues via openalex

[17] Health-related quality of life in women with endometriosis: a systematic review via openalex

[18] Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group via openalex

[19] Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies via openalex

[20] Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group via openalex

[21] Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2) via openalex

[22] Risk of Developing Comorbidities Among Women with Endometriosis: A Retrospective Matched Cohort Study via openalex

[23] Sexual function in endometriosis patients and their partners: effect of the disease and consequences of treatment via openalex

[24] The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis via openalex

[25] The Importance of a Multi-Disciplinary Approach to the Endometriotic Patients: The Relationship between Endometriosis and Psychic Vulnerability via openalex

[26] Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex

[27] Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial via openalex

[28] Treatment of pelvic pain associated with endometriosis: a committee opinion via openalex

[29] Women's experiences of endometriosis: a systematic review and synthesis of qualitative research via openalex

[30] W4386250780 via openalex

[31] W1966648658 via openalex

[32] W2084467580 via openalex

[33] W2109711640 via openalex

[34] W2114736232 via openalex

[35] W2416488540 via openalex

[36] W2417044776 via openalex

[37] W4214754424 via openalex

[38] W4234160457 via openalex